Report Categories
View AllRecent Articles
View All
What Is The Price Target For Fate Therapeutics Fate Stock Fate Q4 2025 Earnings Fate Therapeutics Inc. Posts Narrow Eps Beat No Revenue Reported 20260410 1
Pnnt Stock Analysis Pennantpark Investment Corporation 1.83 Pct Gain At 4.45 Usd 20260403 1
Is Amarin Amrn Stock Showing Strength Price At 14.48 Down 2.03 20260404
Fngr Stock Analysis Fingermotion Inc. Holds Above 1 Dollar With Mild Daily Gain 20260403 1
Daily Market Overview Sp500 And Nasdaq Post Mild Gains Dow Slips 0.13 20260403